Simvastatin/Sitagliptin Phosphate Monohydrate

辛伐他汀/磷酸西格列汀一水合物

Report date: 2023/07/28 10:54:11

Base Information

Drug NameSimvastatin/Sitagliptin Phosphate Monohydrate
Drug Alias Name磷酸西格列汀一水合物/辛伐他汀sitagliptin and simvastatinSitagliptin Phosphate Monohydrate/Simvastatinsitagliptin phosphate monohydrate and simvastatinSimvastatin - sitagliptin phosphate +[7] 
ClassificationSmall molecules
Mechanisms of ActionHMG-CoA reductase inhibitorsDipeptidyl peptidase IV inhibitors
TargetsDipeptidyl peptidase IVHMG-CoA reductase
Therapy Area/IndicationsHypertriglyceridemiaDiabetes Mellitus, Type 2Hyperlipoproteinemia Type II
Global Approved IndicationsHypertriglyceridemiaDiabetes Mellitus, Type 2Hyperlipoproteinemia Type II
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2011/10/07
Country/TerritoryUnited StatesMainland China
CombinationsYes Sitagliptin Phosphate MonohydrateSimvastatin
Global Highest StatusWithdrawn
Highest Status in ChinaDiscontinued
Originator CompaniesMerck Sharp & Dohme Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMerck Sharp & Dohme CorpMerck & Co Inc
Active IndicationsN/A
Inactive IndicationsHypertriglyceridemiaDiabetes Mellitus, Type 2Hyperlipoproteinemia Type II

Other Information

ATC CodeA10BH51
Related LinksKEGG